Edwards Lifesciences Corporation (EW) is scheduled to report second-quarter 2024 results on Jul 24, after market close.In the last reported quarter, the company’s adjusted earnings per share of 66 cents exceeded the Zacks Consensus Estimate by 3.13%. The company’s earnings beat estimates in two of the trailing four quarters and matched estimates in the other two. EW has a trailing four-quarter earnings surprise of 1.17% on average.Q2 EstimatesThe Zacks Consensus Estimate for the company’s second-quarter 202 ...